CAPSTONE INVESTMENT ADVISORS, LLC
Position in FOLD — AMICUS THERAPEUTICS, INC.
CIK 1426196
NEW YORK, NY
Position in FOLD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,842,455
-$22,501,545 QoQ
Shares Held
265,730
-85.6% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#106
of 297 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FOLD Over Time
Shares Held
Position Value (USD)
Derivatives in FOLD
reported options exposure · as of Jun 30, 2020CallValue
$226,200
CallShares
15,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPSTONE INVESTMENT ADVISORS, LLC holds $29,070,840 across 29 Biotechnology names. FOLD ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
250,000 | $10,057,500 | |
| 2 | DAWN |
Day One Biopharmaceuticals, Inc.
|
236,000 | $5,059,840 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
This page
|
265,730 | $3,842,455 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,895 | $1,739,273 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
29,061 | $813,998 | |
| 6 | RPRX |
Royalty Pharma plc
|
14,481 | $694,653 | |
| 7 | ACAD |
Acadia Pharmaceuticals Inc
|
22,735 | $506,081 | |
| 8 | NUVB |
Nuvation Bio Inc.
|
112,170 | $481,209 |
All Filings in FOLD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,842,455 | 265,730 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $26,344,000 | 1,850,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $346,199 | 43,934 | Shares | Defined | 2025-11-14 | |
| 2020-09-30 | $528,836 | 37,453 | Shares | Sole | 2021-06-21 | |
| 2020-06-30 | $338,591 | 22,453 | Shares | Sole | 2021-06-21 | |
| 2020-06-30 | $226,200 | 15,000 | Call | Sole | 2021-06-21 | |
| 2020-03-31 | $496,188 | 53,700 | Call | Sole | 2021-06-21 | |
| No filing history on record for this holder in this stock. | ||||||